Tags

Type your tag names separated by a space and hit enter

[Hormone replacement therapy and cancer].
Tidsskr Nor Laegeforen. 1997 Jun 10; 117(15):2201-7.TN

Abstract

During the last 25 years, the question of hormone replacement therapy (HRT) has been in focus. HRT has proved to reduce the risk of cardiovascular diseases and osteoporotic fractures substantially. However, controversies still remain as regards cancer risk when patients with a history of breast or endometrial cancer are prescribed HRT. Women who take progestins along with oestrogen are not at higher risk of developing endometrial cancer than postmenopausal women who do not take oestrogen are. An overall assessment indicates that long-term HRT may increase the risk of breast cancer slightly. Oestrogen users seem to have a lower risk of developing colon cancer. Prescribing HRT to selected women after a history of endometrial or breast cancer is no longer contra-indicated, but prospective randomised trials are required to test the effect of HRT on overall survival.

Authors+Show Affiliations

Avdeling for gynekologisk onkologi, Det Norske Radiumhospital, Oslo.No affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

nor

PubMed ID

9235712

Citation

Bjørge, T, and C Tropé. "[Hormone Replacement Therapy and Cancer]." Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke, vol. 117, no. 15, 1997, pp. 2201-7.
Bjørge T, Tropé C. [Hormone replacement therapy and cancer]. Tidsskr Nor Laegeforen. 1997;117(15):2201-7.
Bjørge, T., & Tropé, C. (1997). [Hormone replacement therapy and cancer]. Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke, 117(15), 2201-7.
Bjørge T, Tropé C. [Hormone Replacement Therapy and Cancer]. Tidsskr Nor Laegeforen. 1997 Jun 10;117(15):2201-7. PubMed PMID: 9235712.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Hormone replacement therapy and cancer]. AU - Bjørge,T, AU - Tropé,C, PY - 1997/6/10/pubmed PY - 1997/6/10/medline PY - 1997/6/10/entrez SP - 2201 EP - 7 JF - Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke JO - Tidsskr. Nor. Laegeforen. VL - 117 IS - 15 N2 - During the last 25 years, the question of hormone replacement therapy (HRT) has been in focus. HRT has proved to reduce the risk of cardiovascular diseases and osteoporotic fractures substantially. However, controversies still remain as regards cancer risk when patients with a history of breast or endometrial cancer are prescribed HRT. Women who take progestins along with oestrogen are not at higher risk of developing endometrial cancer than postmenopausal women who do not take oestrogen are. An overall assessment indicates that long-term HRT may increase the risk of breast cancer slightly. Oestrogen users seem to have a lower risk of developing colon cancer. Prescribing HRT to selected women after a history of endometrial or breast cancer is no longer contra-indicated, but prospective randomised trials are required to test the effect of HRT on overall survival. SN - 0029-2001 UR - https://www.unboundmedicine.com/medline/citation/9235712/[Hormone_replacement_therapy_and_cancer]_ DB - PRIME DP - Unbound Medicine ER -